UBS Maintains Neutral on Gentex, Lowers Price Target to $25
Benzinga Newsdesk 3 months ago
NewsPrice TargetAnalyst Ratings
UBS analyst Joseph Spak maintains Gentex (NASDAQ:GNTX) with a Neutral and lowers the price target from $26 to $25.
UBS analyst Joseph Spak maintains Gentex (NASDAQ:GNTX) with a Neutral and lowers the price target from $26 to $25.